Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Safety and Immune Response of Different Pediatric Combination Vaccines.

ClinicalTrials.gov ID: NCT00255047

Public ClinicalTrials.gov record NCT00255047. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Comparative Immunogenicity of Different Multivalent Component Pertussis Vaccine Formulations Based on a 5 Component Acellular Pertussis Vaccine in Infants and Toddlers

Study identification

NCT ID
NCT00255047
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi Pasteur, a Sanofi Company
Industry
Enrollment
2,167 participants

Conditions and interventions

Interventions

  • DAPTACEL®. (DTaP), IPOL®., and ActHIB®. Biological
  • Pentacel®: DTaP-IPV/Hib combined Biological
  • DTaP-IPV and ActHIB® Biological

Biological

Eligibility (public fields only)

Age range
42 Days to 89 Days
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2005
Primary completion
Jun 30, 2008
Completion
Jan 31, 2009
Last update posted
Feb 13, 2014

2005 – 2009

United States locations

U.S. sites
36
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Not listed Tuscaloosa Alabama 35401
Not listed Fayetteville Arkansas 72703
Not listed Jonesboro Arkansas 72401
Not listed Little Rock Arkansas 72205
Not listed Fountain Valley California
Not listed Oakland California 94609
Not listed Oakland California 94613
Not listed Oakland California 94618
Not listed Paramount California 90723
Not listed Norwich Connecticut 06360
Not listed Palm Beach Gardens Florida 33410
Not listed Marietta Georgia 30062
Not listed Bardstown Kentucky 40004
Not listed Bossier City Louisiana 71111
Not listed Baltimore Maryland 21201
Not listed Woburn Massachusetts 01801
Not listed Omaha Nebraska 68131
Not listed Ithaca New York
Not listed Liverpool New York 13088
Not listed Huber Heights Ohio 45424
Not listed Youngstown Ohio 44514
Not listed Norristown Pennsylvania 19401
Not listed Pittsburgh Pennsylvania 15227
Not listed Pittsburgh Pennsylvania 15241
Not listed Kingsport Tennessee 37660
Not listed Amarillo Texas 79124
Not listed Fort Worth Texas 76107
Not listed San Antonio Texas 78205
Not listed San Antonio Texas 78229
Not listed Provo Utah 84604
Not listed South Jordan Utah 84095
Not listed St. George Utah 84790
Not listed Spokane Washington 99216
Not listed Vancouver Washington 98664
Not listed Huntington West Virginia 25701
Not listed Marshfield Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00255047, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 13, 2014 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00255047 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →